胃癌分期:CT 表现模式及其与病理所见的相关性
胃腺癌确诊时多为局部进展期,治疗前临床分期至关重要,增强 CT 是肿瘤(T)、淋巴结(N)和转移(M)分期的首选方法。CT 局部 staging 的获益依赖于规范的检查方案,包括禁食、胃腔充盈和静脉对比剂注射;放射科医师需深入掌握胃的大体和微观解剖以评估临床 T 分期,并认识到 CT 在区分 T1 与 T2 期上的准确性有限,以及组织学与影像学多层可视化之间的不匹配。关于 N 和 M 分期,CT 的相关性变异较大:N 分期尚无公认的标准化标准,M 分期的变异主要取决于转移灶的部位。对于腹膜受累,目前推荐对可疑和高危患者行腹腔镜检查。仅 Ia 期、微卫星不稳定患者或急诊病例首选 upfront 手术;Ib 期或更高期别且微卫星稳定状态者目前推荐围手术期化疗。根据这些治疗选择,治疗前临床分期对临床医师正确管理患者具有重要作用。
要点
- 增强 CT 是胃癌治疗前 T、N、M 分期的首选影像方法。
- CT 区分 T1 与 T2 期准确性有限,组织学与影像学多层可视化存在不匹配。
- N 分期尚无公认的标准化 CT 标准,M 分期相关性取决于转移部位。
核心结论
- 治疗前临床分期对胃癌患者管理至关重要,增强 CT 是 T、N、M 分期的首选方法,但需认识其在 T1/T2 区分和 N 分期标准上的局限。
研究设计与样本
- 本文为影像学综述,总结胃癌 CT 分期模式及其与病理所见的相关性,涵盖 T、N、M 分期的 CT 方案、解剖基础和判读要点;原文未报告系统检索范围与纳入文献数量。
诊断标准与关键数值
- CT 局部 staging 的获益与规范方案相关,主要基于禁食、胃腔充盈和静脉对比剂注射。
- CT 区分 T1 与 T2 期准确性有限,且组织学与影像学多层可视化之间存在不匹配。
临床应用与阅片要点
- 放射科医师需深入掌握胃的大体和微观解剖以评估临床 T 分期。
- 对腹膜受累可疑和高危患者,目前推荐行腹腔镜检查。
- 仅 Ia 期、微卫星不稳定患者或急诊病例首选 upfront 手术;Ib 期或更高期别且微卫星稳定状态者目前推荐围手术期化疗。
局限性
- CT 在区分 T1 与 T2 期上准确性有限。
- 组织学与影像学多层可视化之间存在不匹配。
- N 分期尚无公认的标准化标准。
- M 分期的相关性变异主要取决于转移灶的部位。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Gastric adenocarcinoma is mostly locally advanced at diagnosis. An appropriate pretherapy clinical staging is essential, with assistance from contrast-enhanced CT. In primary staging, CT is the first option for tumor (T), nodal (N), and metastatic (M) staging. One of the most relevant radiologic challenges is to reach an accurate TNM staging and reduce the risk of under- or overstaging. The CT benefits for local staging are linked to an appropriate protocol, primarily based on fasting, gastric lumen distention, and administration of intravenous contrast material. It is necessary for radiologists to have a deep knowledge of the macroscopic and microscopic anatomy of the stomach to assess clinical T staging and be aware of limited CT accuracy in the differentiation between stages T1 and T2, and the mismatch between histologic and radiologic multilayer visualization. Regarding N and M staging, the relevance of CT has high variability. For N staging, standardized criteria have not been approved yet, and for M staging, the variability mostly is dependent on the localization of metastatic disease. In peritoneal involvement, laparoscopic examination currently is recommended in doubtful and high-risk patients. Upfront surgery is the first option only in stage Ia, macrosatellite instability patients, or cases of emergency. Perioperative chemotherapy currently is recommended for stage Ib or higher with microsatellite stability status. According to these therapeutic options, pretherapy clinical staging plays an important part for clinicians to manage patients properly. ©RSNA, 2025 Supplemental material is available for this article.
引用
- Di Gregorio F, Polici M, Pilozzi E, et al. Staging of Gastric Cancer: CT Patterns and Correlation with Pathologic Findings. Radiographics. 2025. PMID: 40608556. doi:10.1148/rg.240186
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。